Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04315363
Other study ID # 19-06-05
Secondary ID P30AG048785
Status Completed
Phase N/A
First received
Last updated
Start date November 13, 2020
Est. completion date September 30, 2023

Study information

Verified date February 2024
Source Northeastern University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

In this six-week behavioral intervention, sedentary older adults will receive daily health messaging via their smart phone to better understand their daily activities and emotions. Participants undergo structural and functional brain imaging before and after the intervention along with measures of their behavioral, emotional and thinking functions.


Description:

This project will obtain data on the effects of a six week intervention designed to increase subjects' motivation to increase their physical activity. Subjects will be randomized into two different conditions to examine the efficacy of self-affirmation + positive messaging versus a control group that receives negative messaging only on changes in physical activity. We will also examine whether any differential physical activity or structured exercise engendered in the two groups is maintained at 3 months post-intervention. Secondary outcome measures will include a battery of cognitive, psychosocial, and neuroimaging measures that are designed to explicate the mechanisms that underlie motivation effects for physical activity in sedentary older adults.


Recruitment information / eligibility

Status Completed
Enrollment 40
Est. completion date September 30, 2023
Est. primary completion date October 1, 2022
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 60 Years to 95 Years
Eligibility Inclusion Criteria: - Age range 60-95 - Not exercising more than 150 minutes of moderate/vigorous intensity per week AND sitting more than 8 hours per day - No contraindications to MRI (if opting for MRI) - Being able to speak English fluently - Body Mass Index (BMI) between 20 and 40 - Normal or corrected-normal vision based on the minimal 20/20 standard - Ambulatory without severe pain or the assistance of walking devices - No diagnosis of a neurological disease - Regular access to a computer with internet or smartphone Exclusion Criteria: - Primary care physician does not approve additional physical activity - Inability to ambulate without assistive device - Any unstable medical condition - Current diagnosis of a Diagnostic and Statistical Manual of Mental Disorders (DSM-V) Axis I or II disorder including Major Depression - History of major psychiatric illness including schizophrenia (not including general anxiety disorder or depression) - Current treatment for cancer - except non-melanoma skin - Neurological condition (multiple sclerosis, Parkinson's disease, dementia, mild cognitive impairment) or brain injury (traumatic or stroke) - Current alcohol or substance abuse - Current treatment for congestive heart failure, angina, uncontrolled arrhythmia, deep vein thrombosis or other cardiovascular event - Myocardial infarction, coronary artery bypass grafting, angioplasty or other cardiac condition in the past year - Not passing the Telephone Interview of Cognitive Status (TICS) as normal - Use of any anti-psychotic, anti-depressant, anti-anxiety, and attention deficit disorder (ADD/ADHD) medications.

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Motivational MRI and Behavioral Intervention
Motivational messaging delivered during a functional brain MRI scan and with daily messaging
Control MRI and Behavioral Intervention
Control messaging delivered during a functional brain MRI scan and with daily messaging

Locations

Country Name City State
United States Northeastern University Boston Massachusetts

Sponsors (2)

Lead Sponsor Collaborator
Northeastern University National Institute on Aging (NIA)

Country where clinical trial is conducted

United States, 

References & Publications (1)

Ai M, Morris TP, Ordway C, Quinonez E, D'Agostino F, Whitfield-Gabrieli S, Hillman CH, Pindus DM, McAuley E, Mayo N, de la Colina AN, Phillips S, Kramer AF, Geddes M. The Daily Activity Study of Health (DASH): A pilot randomized controlled trial to enhance physical activity in sedentary older adults. Contemp Clin Trials. 2021 Jul;106:106405. doi: 10.1016/j.cct.2021.106405. Epub 2021 May 1. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Change in Sedentary Behavior (Average Hour/Day) This metric quantifies the change in the average amount of time spent sedentary each day in hours, from the baseline period to the 6-week follow-up period. It is a marker of time spent inactive. Baseline; 6-week
Secondary Change in Moderate-to-Vigorous Physical Activity This measure focuses on the change in average moderate-to-vigorous physical activity (MVPA) daily minutes after the intervention compared to the pre-intervention average MVPA baseline. Baseline; 6-week
See also
  Status Clinical Trial Phase
Completed NCT05433233 - Effects of Lifestyle Walking on Blood Pressure in Older Adults With Hypertension N/A
Recruiting NCT06032065 - Sequential Multiple Assessment Randomized Trial of Exercise for PAD: SMART Exercise for PAD (SMART PAD) Phase 3
Completed NCT05293730 - Trial of the Impact of the Electronic Frailty Integrated With Social Needs N/A
Recruiting NCT03932162 - Gene Expression Changes In Young and Geriatric Skin Early Phase 1
Completed NCT04064528 - Effects of Age on Amino Acid Delivery to Tendon N/A
Completed NCT03366129 - Blood-Brain Barrier Disruption in People With White Matter Hyperintensities Who Have Had a Stroke
Completed NCT06029920 - Influence of Overground Walking on Biomarkers, Cognitive Function, and Quality of Life in Elderly With Mild Cognitive Impairment N/A
Recruiting NCT05543980 - Leg Heat Therapy in Elderly Individuals Phase 2
Recruiting NCT05566938 - Study to Design a Precision Nutrition Strategy at a Group Level in the Elderly N/A
Completed NCT04894929 - Comprehensive Geriatric Assessment in the Monitoring of Functional Improvement N/A
Not yet recruiting NCT06071130 - Emotion, Aging, and Decision Making N/A
Enrolling by invitation NCT04641663 - Multi-target Dietary Supplement Tolerability in an Aging Population (MTDSST) N/A
Completed NCT04088006 - The Evaluation of Efficacy and Safety of Hyaluronic Acid Injection on Skin Moisturization and Elasticity N/A
Completed NCT03695081 - Patient Pathway Pharmacist - Optimal Drug-related Care N/A
Recruiting NCT05424263 - Acetate and Age-associated Arterial Dysfunction Phase 2
Completed NCT05601713 - Mitigating Heat-induced Physiological Strain and Discomfort in Older Adults Via Lower Limb Immersion and Neck Cooling N/A
Completed NCT04551339 - Zinc Versus Multivitamin Micronutrient Supplementation in the Setting of COVID-19 N/A
Recruiting NCT04997577 - Speech Perception and High Cognitive Demand N/A
Completed NCT05922475 - Efficacy of Pre-sleep or Post-exercise Protein During 12 Weeks of Resistance Exercise Training N/A
Completed NCT04015479 - Peanut Protein Supplementation to Augment Muscle Growth and Improve Markers of Muscle Quality and Health in Older Adults N/A